TDOC TDOC テラドック・ヘルスTDOCのチャート
TDOCの企業情報
| symbol | TDOC |
|---|---|
| 会社名 | Teladoc Health Inc （TDOC テラドック・ヘルス） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | 事業概要 テラドック･ヘルス(Teladoc Health Inc.)(旧名:Teladoc Inc.)は遠隔医療会社である。同社はモバイル機器、インターネット、ビデオと電話を通じて、いつでもどこでもオンデマンドヘルスケアを提供するテレヘルスプラットフォームを提供する。同社のソリューションは、上部呼吸器感染症、尿路感染症および副鼻腔炎、皮膚病状、不安および禁煙などの急性診断から、各種病状および症例を治療する3000以上の理事会認定医師および行動医療専門家と会員を結びつける。同社のソリューションは、統合テクノロジープラットフォーム、プロバイダーネットワーク、消費者関与戦略、確立流通チャネルで構成される。 テラドックは、米国の遠隔医療プラットフォ―ム企業。インタ―ネット、ビデオ、携帯電話を利用し、オンデマンドの医療を提供する。登録会員は、上気道感染症、尿路感染症や副鼻腔炎など急性疾患の診断や、皮膚の状態、不安感、禁煙などについて、1100以上の認定医や医療専門家に毎日24時間アクセスできる。本社はニューヨーク州。 Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. |
| 本社所在地 | 203 635-2002 |
| 代表者氏名 | David B. Snow |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 203-635-2002 |
| 設立年月日 | 37408 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 2000人 |
| url | www.teladoc.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） -30.36100 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 3934.63300 |
| 売上高 | 売上高（百万ドル） 417.90700 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 3870.78200 |
| 当期純利益 | 当期純利益（百万ドル） -97.08400 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Teladoc Health Inc revenues increased 79% to $417.9M. Net loss before extraordinary items decreased 17% to $97.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Amortization of warrants and loss on ext decrease from $14.1M (expense) to $0K. |
TDOCのテクニカル分析
TDOCのニュース
Why Teladoc Health Stock Had a Bad Fever Today 2023/03/06 23:32:10 The Motley Fool
It''s not only investors who are getting more bearish on the company in the wake of its latest earnings release.
Teladoc Health, Inc. (TDOC) Cowen 43rd Annual Healthcare Conference Transcript 2023/03/06 20:34:06 Seeking Alpha
Teladoc Health, Inc. (NYSE:NYSE:TDOC) Cowen 43rd Annual Healthcare Conference March 6, 2023 12:50 PM ETCompany ParticipantsPatrick Feeley - Head, Investor RelationsMala Murthy - Chief…
Teladoc PT Lowered to $36 at Canaccord Genuity 2023/03/06 12:56:02 Investing.com
https://www.investing.com/news/pro/teladoc-pt-lowered-to-36-at-canaccord-genuity-432SI-3022864
Teleadoc-owned BetterHelp settles with FTC for data mishandling 2023/03/02 17:53:38 Seeking Alpha
Teleadoc (TDOC)-owned metal health firm BetterHelp has agreed to pay $7.8M in a deal with the Federal Trade Commission ((FTC)) over allegations of data misuse. Read the full story here.
What will the future hold for Teladoc Health Inc. (NYSE:TDOC) stock? 2023/02/28 17:40:00 US Post News
In the current trading session, Teladoc Health Inc.’s (TDOC) stock is trading at the price of $26.83, a fall of -0.63% over last night’s close. So, the stock is trading at a price that is -66.42% less than its 52-week high of $79.90 and 24.21% better than its 52-week low of $21.60. Based on the […]
Teleadoc-owned BetterHelp settles with FTC for data mishandling 2023/03/02 17:53:38 Seeking Alpha
Teleadoc (TDOC)-owned metal health firm BetterHelp has agreed to pay $7.8M in a deal with the Federal Trade Commission ((FTC)) over allegations of data misuse. Read the full story here.
What will the future hold for Teladoc Health Inc. (NYSE:TDOC) stock? 2023/02/28 17:40:00 US Post News
In the current trading session, Teladoc Health Inc.’s (TDOC) stock is trading at the price of $26.83, a fall of -0.63% over last night’s close. So, the stock is trading at a price that is -66.42% less than its 52-week high of $79.90 and 24.21% better than its 52-week low of $21.60. Based on the […]
Teladoc: ''No More Tears Left'' - Great Reset (NYSE:TDOC) 2023/02/27 18:52:22 Seeking Alpha
Teladoc has held its January lows resiliently, despite being battered by a weak outlook for 2023. Read why we reiterate a speculative buy rating for TDOC stock.
Teladoc Hits Low, Down 3.75% 2023/02/27 14:54:02 Investing.com
https://www.investing.com/news/pro/teladoc-hits-low-down-375-432SI-3015775
Teladoc PT Lowered to $33 at JPMorgan 2023/02/27 12:13:22 Investing.com
https://www.investing.com/news/pro/teladoc-pt-lowered-to-33-at-jpmorgan-432SI-3015411
3 Healthcare Stocks to Sell Before They Die 2022/09/30 15:48:49 InvestorPlace
The Fed’s key interest rate target now stands at 3%-3.25%, way up from 0%-0.25% at the beginning of the year. That means, for all companies, borrowing money is becoming much more expensive. As a result, healthcare companies losing a great deal of money will have trouble obtaining new loans they can afford to pay off, and many such firms will go out of business. For investors, it’s essential to avoid the stocks of such companies, and some readers may even want to consider selling the shares of these firms short. To help achieve those goals, I will identify three healthcare stocks to sell before they die. There are a few other important points to consider before reading this column. First, it takes drug makers at least several years to identify a promising drug candidate. Then, it has to run clinical trials, and obtain FDA approval. And the vast majority of drug candidates fail to obtain FDA approval. Meanwhile, due to the increase in interest rates and the Fed’s quantitative tightening program, institutional investors will be much less likely to speculate on healthcare companies that are losing a great deal of money and have little chance of making comebacks.
Down 91%, The Worst Could Be Over For Teladoc 2022/09/30 13:37:00 The Motley Fool
This telehealth company is down but not out yet.
Amid Challenging Backdrop, This Analyst Previews Teladoc Health''s Upcoming Q3 Earnings 2022/09/28 19:20:22 Benzinga
RBC Capital Markets has cut the price target for Teladoc Health Inc (NYSE: TDOC ) from $53 to $35 but reiterates the Outperform rating . The analyst urges some near-term caution into late-October Q3 results based on an increased risk to the guidance given the continued deterioration in the BetterHelp consumer backdrop, particularly into Q4 as mgmt intends to curtail ad spending significantly. RBC does not expect … Full story available on Benzinga.com
1 Green Flag and 1 Red Flag for Teladoc 2022/09/28 10:30:00 The Motley Fool
Can this telemedicine leader rebound?
TDOC vs. DOCS: Skip the Telehealth Poster Child; Consider DOCS Instead 2022/09/27 23:02:57 TipRanks
A few years ago, telehealth services were in a nascent stage, but in 2022, the industry is vibrant and growing, thanks largely to the pandemic. In this piece, we used TipRanks'' Comparison Tool to evaluate two telehealth stocks — TDOC and DOCS. Doximity (NYSE: DOCS) is highly profitable, while Teladoc (NYSE: TDOC) has never been profitable on a GAAP basis. As a result, a bullish view seems appropriate for Doximity in light of this year''s sell-off, while Teladoc seems more deserving of a bearish-to-neutral view.